Skip to main content
. 2020 Jan 15;22(2):212–220. doi: 10.1111/jch.13793

Table 4.

Prevalence of albuminuria and left ventricular hypertrophy according to blood pressure among all patients and patients with HbA1c <7.0%

  Blood pressure (mm Hg)
≥140/90 130‐139/80‐89 <130/80
All patients
Albuminuria
Number of patients (n = 428) 66/207 23/130 12/91
Prevalence of albuminuria (%) 31.9% 17.7% 13.2%
Odds ratio (95% CI)* 0.44 (0.25‐0.76) 0.32 (0.16‐0.64)
P value .003 .001
Left ventricular hypertrophy
Number of patients (n = 766) 19/378 8/223 4/165
Prevalence of left ventricular hypertrophy (%) 5.0% 3.6% 2.4%
Odds ratio (95% CI)* 0.65 (0.27‐1.56) 0.43 (0.14‐1.32)
P value .34 .14
Patients with HbA1c <7.0%
Albuminuria
Number of patients (n = 228) 21/99 13/75 5/54
Prevalence of albuminuria (%) 21.2% 17.3% 9.3%
Odds ratio (95% CI)* 0.75 (0.33‐1.69) 0.33 (0.11‐0.99)
P value .48 .048
Left ventricular hypertrophy
Number of patients (n = 390) 8/173 3/124 1/93
Prevalence of left ventricular hypertrophy (%) 4.6% 2.4% 1.1%
Odds ratio (95% CI)* 0.34 (0.08‐1.54) 0.20 (0.02‐1.79)
P value 0.16 0.15

Abbreviation: CI, confidence interval.

*

Adjusted for age, sex, body mass index, current smoking and alcohol intake, serum total cholesterol and triglycerides, and heart rate.